Back to 
STATE STREET CORP
STATE STREET CORP
SGMOQ28 quarters
Position history for STATE STREET CORP's holdings in SANGAMO THERAPEUTICS, INC
As of its Q1 2026 13F, State Street held 1,694,783 shares of SGMOQ (Sangamo Therapeutics), worth $418,442. State Street's 13F filings listed SGMOQ from Q3 2019 to Q1 2026, 27 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$45.4M
Total Shares Change
-5M
Quarter-by-Quarter History
Other major holders of SGMOQ: WASATCH ADVISORS LP, WELLINGTON MANAGEMENT GROUP LLP